- Home
- AMD vs ABBV Comparison
AMD vs ABBV Comparison
Compare AMD & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMD | ABBV |
|---|---|---|
| Founded | 1969 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.8B | 394.3B |
| IPO Year | 1972 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMD | ABBV |
|---|---|---|
| Price | $211.68 | $226.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 36 | 18 |
| Target Price | $240.03 | ★ $242.28 |
| AVG Volume (30 Days) | ★ 39.9M | 5.5M |
| Earning Date | 02-03-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 3.10% |
| EPS Growth | ★ 78.78 | N/A |
| EPS | ★ 2.02 | 1.32 |
| Revenue | $32,027,000,000.00 | ★ $59,644,000,000.00 |
| Revenue This Year | $33.22 | $10.37 |
| Revenue Next Year | $30.85 | $9.41 |
| P/E Ratio | ★ $104.50 | $169.10 |
| Revenue Growth | ★ 31.82 | 7.40 |
| 52 Week Low | $76.48 | $164.39 |
| 52 Week High | $267.08 | $244.81 |
Technical Indicators
Market Signals| Indicator | AMD | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 42.44 | 50.24 |
| Support Level | $217.91 | $221.10 |
| Resistance Level | $222.49 | $225.98 |
| Average True Range (ATR) | 7.88 | 4.22 |
| MACD | -0.43 | -0.50 |
| Stochastic Oscillator | 54.08 | 46.21 |
Price Performance
Historical ComparisonAbout AMD Advanced Micro Devices Inc.
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers (including artificial intelligence), industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. However, AMD is emerging as a prominent player in AI GPUs and related hardware. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.